- Login
- Register & Subscribe
- Langue: EN FR DE
Research & University News
Conference Report: How Europe can do better in life science
Wednesday 6 April 2011
It is something of a truism to say that money follows success. It is less easy to say why some companies are more successful than others, and how their successes can be repeated.
Location
Belgium
MedImmune and Inserm to collaborate
Tuesday 5 April 2011
The AstraZeneca Plc unit, MedImmune, has entered into a three-year collaboration with the technology transfer arm of France’s National Institute of Health and Medical Research (Inserm) to research disease and potential drug candidates.
Location
France
Amgen lung cancer trial fails to meet primary endpoint
Wednesday 30 March 2011
A Phase-3 study of motesanib, a small molecule antagonist of vascular endothelial growth factor (VEGF) receptors, failed to meet its primary endpoint of improving the overall survival for patients with advanced, non-squamous, non-small cell lung cancer (NSCLC), the sponsor said.
Location
United States
Roche reports on hedgehog pathway inhibitor
Monday 21 March 2011
The Roche group said that its investigational hedgehog pathway inhibitor, vismodegib, which is being developed to treat advanced basal cell carcinoma, met its primary endpoint of overall response in a pivotal Phase 2 clinical study.
Location
Switzerland
Gene therapy achieves a milestone in Parkinson’s disease
Thursday 17 March 2011
A Phase 2 study of a gene therapy for Parkinson’s disease has met its primary endpoint for efficacy and demonstrated safety. The results have been published on-line in The Lancet Neurology, according to the sponsor, Neurologix Inc.
Location
United States
Otelixizumab fails in diabetes trial
Saturday 12 March 2011
Tolerx Inc and GlaxoSmithKline Plc announced that a Phase 3 trial of otelixizumab for patients with new-onset Type 1 diabetes did not meet the primary efficacy endpoint of change in C-peptide, a marker of beta cell function, at 12 months.
Location
United States
Aflibercept fails in NSCLC trial
Saturday 12 March 2011
Sanofi-Aventis SA and its partner, Regeneron Pharmaceuticals Inc, have announced that their Phase 3 trial of the candidate drug, aflibercept, for second-line treatment of non-small cell lung cancer, combined with docetaxel, did not extend overall survival.
Location
France
Généthon and Wake Forest collaborate on gene therapy project
Tuesday 8 March 2011
Généthon, a not-for profit French biotherapy laboratory, has announced a collaboration with the Wake Forest University School of Medicine in the US to work on the preclinical development of a gene therapy for myotubular myopathy.
Location
France
Scientists report transforming stem cells into neurons critical for memory
Saturday 5 March 2011
Scientists from the Northwestern University Feinberg School of Medicine in the US have reported transforming human embryonic stem cells into a type of neuron that plays a critical role in memory. The findings have been published in Stem Cells.
Location
United States
Molecular switch for epidermal stem cells reported
Thursday 3 March 2011
Researchers at Children’s Hospital in Boston, Massachusetts have reported finding a regulator of gene activity that can instruct epidermal stem cells to grow or stop growing, a finding that may have use for cancer as well as regenerative medicine.
Location
United States
Select a News Category
Recent Appointments
Pascale Witz to head strategic development at Sanofi
Monday May 6 2013
Srinivas Akkaraju joins Sofinnova Ventures
Monday May 6 2013
Vicente Anido nominated to Nicox board
Monday May 6 2013
Jeremy Farrar named director of the Wellcome Trust
Monday May 6 2013
Harry Kirsch becomes CFO at Novartis
Monday May 6 2013